Clinical Trial Update: Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial updates on trametinib or combination chemotherapy for refractory or unresectable biliary tract and gallbladder cancers; completed with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bile Duct Cancer
• Cholangiocarcinoma
• Gallbladder Cancer
• Hepatocellular Carcinoma

Drugs mentioned

• Combination chemotherapy
• Trametinib (trametinib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adult Cholangiocarcinoma, Advanced Adult Hepatocellular Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2017-08-10